The Chemours Company
CC
$11.12
$0.464.32%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.80B | 5.80B | 5.81B | 5.80B | 5.90B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.80B | 5.80B | 5.81B | 5.80B | 5.90B |
| Cost of Revenue | 4.70B | 4.65B | 4.68B | 4.68B | 4.68B |
| Gross Profit | 1.10B | 1.15B | 1.13B | 1.12B | 1.22B |
| SG&A Expenses | 581.00M | 596.00M | 530.00M | 556.00M | 591.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.39B | 5.35B | 5.32B | 5.35B | 5.38B |
| Operating Income | 412.00M | 444.00M | 492.00M | 454.00M | 521.00M |
| Income Before Tax | 61.00M | 131.00M | 53.00M | 96.00M | -419.00M |
| Income Tax Expenses | 30.00M | 42.00M | -28.00M | -24.00M | -93.00M |
| Earnings from Continuing Operations | 31.00 | 89.00 | 81.00 | 120.00 | -326.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -2.00M | -2.00M | -2.00M |
| Net Income | 31.00M | 89.00M | 79.00M | 118.00M | -328.00M |
| EBIT | 412.00M | 444.00M | 492.00M | 454.00M | 521.00M |
| EBITDA | 719.00M | 745.00M | 789.00M | 749.00M | 820.00M |
| EPS Basic | 0.21 | 0.60 | 0.53 | 0.79 | -2.20 |
| Normalized Basic EPS | 0.79 | 0.95 | 1.11 | 0.98 | 1.35 |
| EPS Diluted | 0.19 | 0.58 | 0.51 | 0.77 | -2.21 |
| Normalized Diluted EPS | 0.79 | 0.95 | 1.10 | 0.98 | 1.35 |
| Average Basic Shares Outstanding | 598.86M | 597.97M | 597.01M | 595.93M | 595.62M |
| Average Diluted Shares Outstanding | 599.57M | 599.70M | 598.73M | 599.22M | 598.19M |
| Dividend Per Share | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Payout Ratio | 477.42% | 166.29% | 188.61% | 125.42% | -45.43% |